Voya Investment Management LLC Aerie Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $5,172 - $12,366	812 Added 4.53%	18,732 $283,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $6,534 - $12,091	1,320 Added 7.95%	17,920 $134,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $1,077 - $1,871	-191 Reduced 1.14%	16,600 $151,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $1.29 Million - $2.45 Million	-184,032 Reduced 91.64%	16,791 $118,000
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $117,060 - $171,970	-10,341 Reduced 4.9%	200,823 $2.29 Million
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $99,661 - $124,708	-6,574 Reduced 3.02%	211,164 $3.38 Million
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $5.98 Million - $9.52 Million	-455,530 Reduced 67.66%	217,738 $3.89 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $655,791 - $1.04 Million	71,907 Added 11.96%	673,268 $9.1 Million
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $125,938 - $174,098	12,040 Added 2.04%	601,361 $7.08 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $310,572 - $417,460	-25,881 Reduced 4.21%	589,321 $8.7 Million
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $45,276 - $97,588	-3,824 Reduced 0.62%	615,202 $8.31 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $1.91 Million - $2.7 Million	-107,676 Reduced 14.82%	619,026 $15 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $4.9 Million - $7.46 Million	266,296 Added 57.84%	726,702 $14 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $455,350 - $757,764	15,718 Added 3.53%	460,406 $13.6 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $1.97 Million - $2.67 Million	-54,264 Reduced 10.88%	444,688 $21.1 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $2.7 Million - $4.92 Million	81,892 Added 19.64%	498,952 $18 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.76 Million - $2.32 Million	31,367 Added 8.13%	417,060 $25.7 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $3.34 Million - $4.91 Million	-69,757 Reduced 15.32%	385,693 $26.1 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $2.94 Million - $3.51 Million	57,522 Added 14.46%	455,450 $24.7 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $5.28 Million - $6.76 Million	-103,813 Reduced 20.69%	397,928 $23.8 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $24.4 Million - $30.2 Million	501,741	501,741 $24.4 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account